Researchers stripped a virus of its infectious machinery and turned its benign core into a delivery vehicle that can target sick cells while leaving healthy tissue alone.
By Tom Abate
Stanford researchers have ripped the guts out of a virus and totally redesigned its core to repurpose its...
Stanford scientists produced a common cancer drug – previously only available from an endangered plant – in a common laboratory plant. This work could lead to a more stable supply of the drug and allow scientists to manipulate that drug to make it even safer and more effective.
It typically takes a year to produce hydrocodone from plants, but Christina Smolke, a Stanford ChEM-H fellow, and colleagues have genetically modified yeast to make it in just a few days. The technique could improve access to medicines in impoverished nations, and later be used to develop...
Formaldehyde is excellent for preserving cellular structures, but it makes it difficult to pull genetic information from tissue samples. Eric Kool and colleagues including a ChEM-H fellow have developed a catalyst that saves RNA, which could lead to better patient outcomes.
By Bjorn Carey
Carolyn Bertozzi sees chemicals as having personalities and those personalities determine how they behave. She's bringing this vision to her teaching, hoping to help chemistry and biology students as well as the general public understand what's exciting in chemistry.
By Amy Adams
Researchers have figured out how to create spheres of neuronal cells resembling the cerebral cortex, making functional human brain tissue available for the first time to study neuropsychiatric diseases such as autism and schizophrenia.
Stanford ChEM-H scientists are helping to develop a novel cancer therapy based on a new finding of a protein that inadvertently promotes cancer growth. Blocking this protein could help block the growth of many types of tumors.
The discovery of a new mechanism of DNA damage could offer new insights into cancer and neurodegenerative disease, and also reveals a surprising role for messenger RNA, the molecule that forms the genetic transcript.
The retinoblastoma protein inhibits cancer by controlling cell division. Now, researchers have shown that it also binds to and inhibits genes necessary for pluripotency — a defining characteristic of stem cells.
During its recent meeting, the university's Board of Trustees visited the new Anderson Collection at Stanford University, gave preliminary approval to two new campus buildings and gave final approval to three construction projects, including new residences for undergraduates and for first-year...
The Nobel Prize-winning microscopy techniques developed in part by Stanford's W.E. Moerner have allowed scientists to visualize precise molecular mechanisms inside living cells, opening new windows to how life can be studied.